Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-03-27 17:00 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
156,000 | |
Filed 2024-01-12 14:29 Tx date 2023-11-06 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-12,500 vol |
30,002 | |
Filed 2024-01-12 14:28 Tx date 2023-10-30 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-17,502 vol |
42,502 | |
Filed 2022-11-03 18:37 Tx date 2021-05-26 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
72 - Other settlement of third party derivative
|
+3,622 vol |
28,622 | |
Filed 2022-10-27 13:21 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
106,000 | |
Filed 2022-01-28 13:13 Tx date 2022-01-10 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
72 - Other settlement of third party derivative
|
+31,382 vol |
56,382 | |
Filed 2020-12-15 12:50 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$115,500
+16,500 vol $7.00 each |
83,500 | |
Filed 2020-08-04 13:03 Tx date 2020-07-31 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$150,000
+25,000 vol $6.00 each |
25,000 | |
Filed 2020-08-04 13:02 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-01 15:39 Tx date 2019-10-30 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,750
+25,000 vol $4.67 each |
67,000 | |
Filed 2019-10-16 13:37 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,750
+25,000 vol $3.23 each |
42,000 | |
Filed 2019-04-26 18:07 Tx date 2019-01-31 |
$VBIV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
287,500 | |
Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$19,050
+5,000 vol $3.81 each |
17,000 | |
Filed 2018-06-18 Tx date 2018-06-14 |
$VBIV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+12,500 vol |
37,500 | |
Filed 2018-06-18 Tx date 2018-06-14 |
$VBIV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
-12,500 vol |
12,500 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-228,000 vol |
12,000 | |
Filed 2018-03-05 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+240,000 vol $0.20 each |
240,000 | |
Filed 2018-01-26 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
87,500 | |
Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+12,500 vol |
25,000 | |
Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
-12,500 vol |
25,000 | |
Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
$-48,375
-12,500 vol $3.87 each |
37,500 | |
Filed 2017-04-07 Tx date 2017-01-26 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
12,500 | |
Filed 2017-04-07 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$48,375
+12,500 vol $3.87 each |
12,500 | |
Filed 2017-04-07 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
56 - Grant of rights
|
+50,000 vol |
50,000 | |
Filed 2017-04-07 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|